These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10074129)

  • 1. Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis.
    McCright IJ; Tsunoda I; Whitby FG; Fujinami RS
    J Virol; 1999 Apr; 73(4):2814-24. PubMed ID: 10074129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
    Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
    Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus.
    McCright IJ; Tsunoda I; Libbey JE; Fujinami RS
    J Neurovirol; 2002 Apr; 8(2):100-10. PubMed ID: 11935462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.
    Senkowski A; Shim B; Roos RP
    J Neurovirol; 1995 Mar; 1(1):101-10. PubMed ID: 9222346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of loop II of VP1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence, and demyelination.
    Wada Y; McCright IJ; Whitby FG; Tsunoda I; Fujinami RS
    J Virol; 1998 Sep; 72(9):7557-62. PubMed ID: 9696853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.
    Tsunoda I; Wada Y; Libbey JE; Cannon TS; Whitby FG; Fujinami RS
    J Virol; 2001 Aug; 75(16):7494-505. PubMed ID: 11462022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease.
    Wada Y; Pierce ML; Fujinami RS
    J Virol; 1994 Feb; 68(2):1219-23. PubMed ID: 8289355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric Theiler's virus with altered tropism for the central nervous system.
    Jarousse N; Fiette L; Grant RA; Hogle JM; McAllister A; Michiels T; Aubert C; Tangy F; Brahic M; Peña Rossi C
    J Virol; 1994 May; 68(5):2781-6. PubMed ID: 8151749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.
    Jnaoui K; Minet M; Michiels T
    J Virol; 2002 Aug; 76(16):8138-47. PubMed ID: 12134019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single amino acid change determines persistence of a chimeric Theiler's virus.
    Jarousse N; Grant RA; Hogle JM; Zhang L; Senkowski A; Roos RP; Michiels T; Brahic M; McAllister A
    J Virol; 1994 May; 68(5):3364-8. PubMed ID: 7512164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.
    Jnaoui K; Michiels T
    Virology; 1998 May; 244(2):397-404. PubMed ID: 9601508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential induction of IL-10 in APC correlates with a switch from Th1 to Th2 response following infection with a low pathogenic variant of Theiler's virus.
    Palma JP; Yauch RL; Kang HK; Lee HG; Kim BS
    J Immunol; 2002 Apr; 168(8):4221-30. PubMed ID: 11937584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of sialyloligosaccharide binding in Theiler's virus persistence.
    Zhou L; Lin X; Green TJ; Lipton HL; Luo M
    J Virol; 1997 Dec; 71(12):9701-12. PubMed ID: 9371636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theiler's murine encephalomyelitis virus (TMEV): the role of a small out-of-frame protein in viral persistence and demyelination.
    Obuchi M; Ohara Y
    Jpn J Infect Dis; 1999 Dec; 52(6):228-33. PubMed ID: 10738359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The generation and characterisation of neutralising antibodies against the Theiler's murine encephalomyelitis virus (TMEV) GDVII capsid reveals the potential binding site of the host cell co-receptor, heparan sulfate.
    Upfold N; Ross C; Bishop ÖT; Luke GA; Knox C
    Virus Res; 2018 Jan; 244():153-163. PubMed ID: 29155139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses.
    Adami C; Pritchard AE; Knauf T; Luo M; Lipton HL
    J Virol; 1998 Feb; 72(2):1662-5. PubMed ID: 9445074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptors.
    Kumar AS; Reddi HV; Kung AY; Dal Canto M; Lipton HL
    J Virol; 2004 Aug; 78(16):8860-7. PubMed ID: 15280494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype.
    Sato S; Zhang L; Kim J; Jakob J; Grant RA; Wollmann R; Roos RP
    Virology; 1996 Dec; 226(2):327-37. PubMed ID: 8955052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system.
    Jarousse N; Martinat C; Syan S; Brahic M; McAllister A
    J Virol; 1996 Nov; 70(11):8213-7. PubMed ID: 8892956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding.
    Tsunoda I; Libbey JE; Fujinami RS
    J Neurovirol; 2009 Jan; 15(1):81-9. PubMed ID: 19115131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.